BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (N-Term) Peptid
BIK
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle BIK Produkte
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- SEVRPLSRDI LMETLLYEQL LEPPTMEVLG MTDSEEDLDP MEDFDSLECM
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BIK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
- Synonyme
- BIK Peptide, Biklk Peptide, Blk Peptide, Nbk Peptide, BIP1 Peptide, BP4 Peptide, NBK Peptide, si:dkey-31f5.6 Peptide, BCL2 interacting killer Peptide, BCL2-interacting killer Peptide, BCL2-interacting killer (apoptosis-inducing) Peptide, BIK Peptide, Bik Peptide, bik Peptide
- Hintergrund
-
The protein encoded by this gene shares a critical BH3 domain with other death-promoting proteins, such as BID, BAK, BAD and BAX, that is required for its pro-apoptotic activity, and for interaction with anti-apoptotic members of the BCL2 family, and viral survival-promoting proteins. Since the activity of this protein is suppressed in the presence of survival-promoting proteins, it is suggested as a likely target for anti-apoptotic proteins.
Alias Symbols: BIK,NBK,
Protein Size: 160 - Gen-ID
- 638
- NCBI Accession
- NP_001188
- UniProt
- Q13323
-
Sie sind hier:
